Lenvatinib Mesylate and Olaratumab Intravenous
Determining the interaction of Lenvatinib Mesylate and Olaratumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: olaratumab
Brand name: Lartruvo
Synonyms: Olaratumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Oleptro
- Lenvatinib Mesylate-Oleptro Oral
- Lenvatinib Mesylate-Olmesartan
- Lenvatinib Mesylate-Olmesartan and Hydrochlorothiazide
- Lenvatinib Mesylate-Olmesartan Medoxomil
- Lenvatinib Mesylate-Olmesartan Medoxomil and Hydrochlorothiazide
- Olaratumab Intravenous-Lenvima
- Olaratumab Intravenous-Lenvima (14 MG Daily Dose)
- Olaratumab Intravenous-Lenvima (18 MG Daily Dose)
- Olaratumab Intravenous-Lenvima (20 MG Daily Dose)
- Olaratumab Intravenous-Lenvima (24 MG Daily Dose)
- Olaratumab Intravenous-Lenvima (8 MG Daily Dose)